Fellowship · Houston, TX
Sponsored by University of Texas Health Science Center at Houston
Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors.
Nature reviews. Nephrology · 2021 · 504 citations · William Reeves
Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC).
eLife · 2023 · 191 citations · William Reeves
Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy.
Nature genetics · 2023 · 171 citations · Scott Wenderfer
Diagnosis and management of immune checkpoint inhibitor-associated nephrotoxicity: a position statement from the American Society of Onco-nephrology.
Kidney international · 2025 · 44 citations · Jaya Kala
Clinical Management of Hyperkalemia.
Mayo Clinic proceedings · 2021 · 142 citations · Macaulay Onuigbo
Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis.
Arthritis & rheumatology (Hoboken, N.J.) · 2021 · 163 citations · Amber Podoll
A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant.
Kidney international · 2021 · 151 citations · Shana Machado
Glycolytic lactate in diabetic kidney disease.
JCI insight · 2024 · 54 citations · William Reeves